Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-16-089766

SVP, General Counsel, Sec. sold 1,811 shares at $12.28 ($22,239)

From the SEC's structured data for this filing

Trades in this filing

Hadas Nicole R. · SVP, General Counsel, Sec.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-01-04 Sale : show line 1 in the form −1,811 $12.28 $22,239 64,584 D
Open-market sales · 1,811 sh · avg $12.28 · $22,239
Loading xslF345X03/doc4.xml…